SoftBank Group Corp. announced Wednesday that it has launched a subsidiary that will conduct polymerase chain reaction (PCR) coronavirus tests using saliva, with the aim of providing more tests at a lower cost.
To start, SoftBank said it will conduct the tests on its employees and members of the SoftBank Hawks, the professional baseball team that is part of the SoftBank group, by working with the National Center for Global Health and Medicine, the telecom and investment giant said in a statement.
SoftBank said it is talking with the National Center for Global Health and Medicine to conduct joint research on how more tests and early detection can help prevent the spread of the disease.
The new firm will also help provide PCR tests for those companies or municipalities that wish to do so, saying if it makes a profit, it will donate funds to medical institutions.
SoftBank recently conducted coronavirus antibody tests on its more than 40,000 employees, medical workers and others, 0.43 percent of which tested positive
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
Your news needs your support
Since the early stages of the COVID-19 crisis, The Japan Times has been providing free access to crucial news on the impact of the novel coronavirus as well as practical information about how to cope with the pandemic. Please consider subscribing today so we can continue offering you up-to-date, in-depth news about Japan.